Suspended
Predictive Value of C-Reactive Protein in Acute Diverticulitis
What is being collected
Data Collection
Collected from today forward - ProspectiveOther
Who is being recruted
From 18 to 90 Years
+2 Eligibility Criteria
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: April 2013
Summary
Principal SponsorCorporacion Parc Tauli
Study ContactMORA L. LAURA, MDMore contacts
Last updated: April 10, 2013Sourced from a government-validated database.Claim as a partner
Study start date: April 1, 2013
Actual date on which the first participant was enrolled.A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test. The investigators will predict evolution of AD with the PCR initial.
Principal SponsorCorporacion Parc Tauli
Study ContactMORA L. LAURA, MDMore contacts
Last updated: April 10, 2013Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 18 to 90 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
1 inclusion criteria required to participate
Acute Diverticulitis
1 exclusion criteria prevent from participating
Other Abdominal Pathologies
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 4 locations
Corporacion parc tauli
Sabadell, SpainCorporacion Parc Tauli
Sabadell, SpainCorporacion Parc Tauli
Sabadell, SpainSuspended4 Study Centers